XML 62 R50.htm IDEA: XBRL DOCUMENT v3.25.1
Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | segment 2  
Segment Reporting Information [Line Items]    
Net sales $ 5,866 $ 5,243
Reclassification to: cost of sales 2,122 1,910
Research, development and engineering expenses 405 368
Selling, general and administrative expenses 2,300 1,837
Depreciation and amortization 361 355
Amortization of intangible assets (167) (153)
Segment operating income 837 972
Goodwill and other impairments (35) (3)
Net earnings 654 788
MedSurg and Neurotechnology:    
Segment Reporting Information [Line Items]    
Net sales 3,511 3,097
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 5,866 5,243
Reclassification to: cost of sales 1,950 1,829
Research, development and engineering expenses 366 329
Selling, general and administrative expenses 1,784 1,514
Depreciation and amortization 155 162
Amortization of intangible assets (167) (153)
Segment operating income 1,611 1,409
Operating Segments | MedSurg and Neurotechnology:    
Segment Reporting Information [Line Items]    
Net sales 3,511 3,097
Reclassification to: cost of sales 1,321 1,238
Research, development and engineering expenses 226 195
Selling, general and administrative expenses 937 763
Depreciation and amortization 57 54
Segment operating income 970 847
Operating Segments | Orthopaedics    
Segment Reporting Information [Line Items]    
Net sales 2,355 2,146
Reclassification to: cost of sales 629 591
Research, development and engineering expenses 140 134
Selling, general and administrative expenses 847 751
Depreciation and amortization 98 108
Segment operating income 641 562
Segment Reporting, Reconciling Item, Corporate Nonsegment    
Segment Reporting Information [Line Items]    
Depreciation and amortization 39 40
Segment operating income (267) (263)
Segment Reconciling Items    
Segment Reporting Information [Line Items]    
Sale of inventory stepped up to fair value at acquisition (34) 0
Acquisition and integration-related charges (185) 13
Structural optimization and other special charges (41) (11)
Goodwill and other impairments (35) (3)
Medical device regulation (12) (13)
Recall-related matters (33) (5)
Regulatory and legal matters 0 (2)
Net earnings $ 837 $ 972